Literature DB >> 21605475

Community-acquired bacteremia and acute cholecystitis due to Enterobacter cloacae: a case report.

Guillermo Isasti, Laura Mora, Victoria García, Jesus Santos, Rosario Palacios.   

Abstract

INTRODUCTION: Enterobacter cloacae is responsible for 65-75% of all Enterobacter infections, bacteremia being the most common syndrome. The majority of infections are nosocomially acquired and in patients with predisposing factors. CASE
PRESENTATION: We present a case of E. cloacae bacteremia secondary to acute cholecystitis in a 60-year-old man with recent diagnosis of cholelithiasis. The diagnosis was established with abdominal echography and positive blood and biliary cultures. The patient was managed successfully with cholecystectomy and antibiotic therapy.
CONCLUSION: The peculiarity of our case is the development of community-acquired bacteremia due to E. cloacae with a clear infectious focus, as a single agent isolated in several blood cultures, in a patient without severe underlying diseases, prior antimicrobial use or previous hospital admission. Although the majority of Enterobacter spp. infections are nosocomially acquired, primary bacteremia being the most common syndrome, these pathogens may also be responsible for community-acquired cases. Patients without predisposing factors may also be affected.

Entities:  

Year:  2009        PMID: 21605475      PMCID: PMC2827163          DOI: 10.4076/1752-1947-3-7417

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  10 in total

Review 1.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.

Authors:  Y Ye; J B Li; D Q Ye; Z J Jiang
Journal:  Infection       Date:  2006-10       Impact factor: 3.553

3.  Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.

Authors:  Yi Chun Lin; Te Li Chen; Huang Ling Ju; Huan Shen Chen; Fu Der Wang; Kwok Woon Yu; Chen Yi Liu
Journal:  J Microbiol Immunol Infect       Date:  2006-02       Impact factor: 4.399

4.  Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens.

Authors:  A Forsgren; M Walder
Journal:  APMIS       Date:  1994-03       Impact factor: 3.205

5.  Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery.

Authors:  D M Flynn; R A Weinstein; C Nathan; M A Gaston; S A Kabins
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

6.  Enterobacter bacteremia. An analysis of 50 episodes.

Authors:  E Bouza; M García de la Torre; A Erice; E Loza; J M Diaz-Borrego; L Buzón
Journal:  Arch Intern Med       Date:  1985-06

7.  Retrospective analysis of bacteremia because of Enterobacter cloacae compared with Escherichia coli bacteremia.

Authors:  D Juanjuan; Z Zhiyong; L Xiaoju; X Yali; Z Xihai; L Zhenzhen
Journal:  Int J Clin Pract       Date:  2007-04       Impact factor: 2.503

8.  Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group.

Authors:  S Chamberland; J L'Ecuyer; C Lessard; M Bernier; P Provencher; M G Bergeron
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

9.  Retrospective 6-year study of enterobacter bacteraemia in a Danish university hospital.

Authors:  M Weischer; H J Kolmos
Journal:  J Hosp Infect       Date:  1992-01       Impact factor: 3.926

10.  An increased incidence of Enterobacter cloacae in a cardiovascular ward.

Authors:  K Kanemitsu; S Endo; K Oda; K Saito; H Kunishima; M Hatta; K Inden; M Kaku
Journal:  J Hosp Infect       Date:  2007-05-18       Impact factor: 3.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.